104 related articles for article (PubMed ID: 27351183)
1. 99mTc-DPD-scintigraphy with intense uptake in fat tissue caused by AL-amyloidosis.
Zoller M; Hajnos G; Burkhard R; Kneifel S
Eur J Nucl Med Mol Imaging; 2016 Nov; 43(12):2269-2270. PubMed ID: 27351183
[No Abstract] [Full Text] [Related]
2. Noninvasive etiologic diagnosis of cardiac amyloidosis using 99mTc-3,3-diphosphono-1,2-propanodicarboxylic acid scintigraphy.
Perugini E; Guidalotti PL; Salvi F; Cooke RM; Pettinato C; Riva L; Leone O; Farsad M; Ciliberti P; Bacchi-Reggiani L; Fallani F; Branzi A; Rapezzi C
J Am Coll Cardiol; 2005 Sep; 46(6):1076-84. PubMed ID: 16168294
[TBL] [Abstract][Full Text] [Related]
3. Role of cardiac scintigraphy with ⁹⁹mTc-DPD in the differentiation of cardiac amyloidosis subtype.
de Haro-del Moral FJ; Sánchez-Lajusticia A; Gómez-Bueno M; García-Pavía P; Salas-Antón C; Segovia-Cubero J
Rev Esp Cardiol (Engl Ed); 2012 May; 65(5):440-6. PubMed ID: 22464102
[TBL] [Abstract][Full Text] [Related]
4. Utility and limitations of 3,3-diphosphono-1,2-propanodicarboxylic acid scintigraphy in systemic amyloidosis.
Hutt DF; Quigley AM; Page J; Hall ML; Burniston M; Gopaul D; Lane T; Whelan CJ; Lachmann HJ; Gillmore JD; Hawkins PN; Wechalekar AD
Eur Heart J Cardiovasc Imaging; 2014 Nov; 15(11):1289-98. PubMed ID: 24939945
[TBL] [Abstract][Full Text] [Related]
5. Unusual high 99mTc-3,3-diphosphono-1,2-propanodicarboxylic acid (99mTc-DPD) tracer deposition on a heart scintigraphy in a patient with AL amyloidosis: A case report.
Persia-Paulino YR; Cuevas-Perez J; Fernandez-Asensio R; Junco-Vicente A; Rozado-Castano J; Colunga S; Cigarran H; Calvo J; Laverde A; Persia O; Capin-Sampedro E
J Nucl Cardiol; 2021 Jun; 28(3):1117-1125. PubMed ID: 32333280
[TBL] [Abstract][Full Text] [Related]
6. Quantitative
Caobelli F; Braun M; Haaf P; Wild D; Zellweger MJ
J Nucl Cardiol; 2020 Oct; 27(5):1456-1463. PubMed ID: 31538322
[TBL] [Abstract][Full Text] [Related]
7. Etiology of amyloidosis determines myocardial 99mTc-DPD uptake in amyloidotic cardiomyopathy.
Longhi S; Bonfiglioli R; Obici L; Gagliardi C; Milandri A; Lorenzini M; Guidalotti PL; Merlini G; Rapezzi C
Clin Nucl Med; 2015 May; 40(5):446-7. PubMed ID: 25742226
[TBL] [Abstract][Full Text] [Related]
8. 99mTc-DPD scintigraphy and SPECT/CT in patients with AL and ATTR type amyloidosis: Potential clinical implications.
Lee J; Kim K; Choi JO; Kim SJ; Jeon ES; Choi JY
Medicine (Baltimore); 2020 Jan; 99(4):e18905. PubMed ID: 31977903
[TBL] [Abstract][Full Text] [Related]
9. 99mTc-DPD scintigraphy in immunoglobulin light chain (AL) cardiac amyloidosis.
Quarta CC; Zheng J; Hutt D; Grigore SF; Manwani R; Sachchithanantham S; Mahmood SA; Whelan CJ; Fontana M; Martinez-Naharro A; Chacko L; Lachmann HJ; Gillmore JD; Rapezzi C; Hawkins PN; Wechalekar AD
Eur Heart J Cardiovasc Imaging; 2021 Oct; 22(11):1304-1311. PubMed ID: 34254119
[TBL] [Abstract][Full Text] [Related]
10. Puzzling intestinal uptake in 99mTc-DPD bone scintigraphy.
Hodek-Wuerz R; Walter MA; Mueller-Brand J
Nuklearmedizin; 2006; 45(4):N41. PubMed ID: 16969952
[No Abstract] [Full Text] [Related]
11. Gastric accumulation of bone seeking agent in a patient with advanced gastric cancer.
Kim DW; Jeong HJ; Park SA; Kim CG
J Korean Med Sci; 2007 Feb; 22(1):153-5. PubMed ID: 17297271
[TBL] [Abstract][Full Text] [Related]
12. Usefulness of 99mTc-DPD scintigraphy in cardiac amyloidosis.
Rapezzi C; Guidalotti P; Salvi F; Riva L; Perugini E
J Am Coll Cardiol; 2008 Apr; 51(15):1509-10; author reply 1510. PubMed ID: 18402909
[No Abstract] [Full Text] [Related]
13. Myocardial uptake of bone scintigraphic agents associated with increased pulmonary uptake.
Bach-Gansmo T; Wien TN; Løndalen A; Halvorsen E
Clin Physiol Funct Imaging; 2016 May; 36(3):237-41. PubMed ID: 25524030
[TBL] [Abstract][Full Text] [Related]
14. 99mTc-aprotinin scintigraphy in amyloidosis.
Schaadt BK; Hendel HW; Gimsing P; Jønsson V; Pedersen H; Hesse B
J Nucl Med; 2003 Feb; 44(2):177-83. PubMed ID: 12571206
[TBL] [Abstract][Full Text] [Related]
15. (99m)Tc-DPD uptake reflects amyloid fibril composition in hereditary transthyretin amyloidosis.
Pilebro B; Suhr OB; Näslund U; Westermark P; Lindqvist P; Sundström T
Ups J Med Sci; 2016; 121(1):17-24. PubMed ID: 26849806
[TBL] [Abstract][Full Text] [Related]
16. Spleen visualization in both TTR and AL amyloidosis during
Koutelou M; Tziomalos G; Chatzoglou V; Pappas N; Papanastasiou E; Chatzipavlidou V; Doumas A
Hell J Nucl Med; 2023; 26(2):140-144. PubMed ID: 37527050
[TBL] [Abstract][Full Text] [Related]
17. 99mTc DPD is the preferential bone tracer for diagnosis of cardiac transthyretin amyloidosis.
Rossi P; Tessonnier L; Frances Y; Mundler O; Granel B
Clin Nucl Med; 2012 Aug; 37(8):e209-10. PubMed ID: 22785530
[TBL] [Abstract][Full Text] [Related]
18. Calciphylaxis, a cause of ⁹⁹mTc-diphosphonate soft-tissue uptake.
Ramos-Font C; Sanchez de Mora E; López Martín J; Salgado-García C; Benitez-Sanchez M; Jimenez-Heffernan A
Rev Esp Med Nucl Imagen Mol; 2015; 34(2):153-4. PubMed ID: 25151175
[No Abstract] [Full Text] [Related]
19. Role of (99m)Tc-DPD scintigraphy on discrimination of familial cardiac amyloidosis.
Ferreira SG; Rocha AM; Moreira do Nascimento OJ; Mesquita CT
Int J Cardiol; 2016 Jan; 203():885-7. PubMed ID: 26605689
[No Abstract] [Full Text] [Related]
20. Extraosseous uptake with DPD (Teceos(®)).
Bach-Gansmo T; Bogsrud TV; Holmboe L; Pedersen EL; Müller C
Clin Physiol Funct Imaging; 2011 Sep; 31(5):358-62. PubMed ID: 21771254
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
